卡格列凈是一種選擇性的 SGLT2 抑制劑，在CHOK 細(xì)胞中，抑制 mSGLT2，rSGLT2 和 hSGLT2，IC50 分別為 2 nM，3.7 nM 和 4.4 nM。 是一種治療2型糖尿病的藥物。
(2S,3R,4R,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol hemihydrate
2-(4-Fluorophenyl)-5-(5-iodo-2-methylbenzyl)thiophene
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
(2R,3R,4R,5S,6S)-2-(Acetoxymethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate
2-(4-Fluorophenyl)thiophene
(2R,3R,4S,5R,6R)-2-Bromo-6-((pivaloyloxy)methyl)tetrahydro-2H-pyran-3,4,5-triyl tris(2,2-dimethylpropanoate)
(5-Bromo-2-methylphenyl)(5-(4-fluorophenyl)thiophen-2-yl)methanone
2,3,4,6-Tetra-O-(trimethylsilyl)-D-glucono-delta-lactone
5-Bromo-2-methylbenzoic acid
2-Bromothiophene
(3R,4S,5S,6R)-2-(3-((5-(4-Fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5-triol
5-Bromo-2-methylbenzoyl chloride
1,2,3,4,6-Penta-o-pivaloyl-d-glucopyranoside
(2R,3R,4S,5R)-2-(Acetoxymethyl)-6-oxotetrahydro-2H-pyran-3,4,5-triyl triacetate
